We describe the use of hyoscine butylbromide as a subcutaneous infusion in 3 patients with inoperable malignant bowel obstruction. An objective reduction of drainage from the gastrointestinal tract was observed with the hyoscine butylbromide infusion (60-120 mg/day). We suggest that this effect can be useful in the palliative treatment of vomiting in inoperable bowel obstruction.
Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction / F. De Conno, A. Caraceni, E. Zecca, E. Spoldi, V. Ventafridda. - In: JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. - ISSN 0885-3924. - 6:8(1991 Nov), pp. 484-486. [10.1016/0885-3924(91)90005-O]
Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction
A. CaraceniSecondo
;
1991
Abstract
We describe the use of hyoscine butylbromide as a subcutaneous infusion in 3 patients with inoperable malignant bowel obstruction. An objective reduction of drainage from the gastrointestinal tract was observed with the hyoscine butylbromide infusion (60-120 mg/day). We suggest that this effect can be useful in the palliative treatment of vomiting in inoperable bowel obstruction.
| File | Dimensione | Formato | |
|---|---|---|---|
|
main8.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
243.03 kB
Formato
Adobe PDF
|
243.03 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
